Report cover image

Alternative to Antibiotics Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 146 Pages
SKU # APRC20353029

Description

Summary

According to APO Research, the global Alternative to Antibiotics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Alternative to Antibiotics include DSM, BioGaia, Bioriginal, Biosearch Life, China-Biotics, Chr. Hansen, Danone, DuPont(Danisco) and Ganeden, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alternative to Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alternative to Antibiotics.

The report will help the Alternative to Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Alternative to Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alternative to Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Alternative to Antibiotics Segment by Company

DSM
BioGaia
Bioriginal
Biosearch Life
China-Biotics
Chr. Hansen
Danone
DuPont(Danisco)
Ganeden
Glory Biotech
Greentech
Lallemand
Morinaga Milk Industry
Novozymes
Probi
Sabinsa
Synbiotech
UAS Laboratories
Valio
Yakult
Nestle
Alternative to Antibiotics Segment by Type

Antimicrobial Proteins
Bacteriophages
Probiotics
Other
Alternative to Antibiotics Segment by Application

Drugs
Food & Beverage
Dietary Supplements
Alternative to Antibiotics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative to Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alternative to Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative to Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alternative to Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alternative to Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alternative to Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

146 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Alternative to Antibiotics Market Size (2020-2031)
2.2.2 Global Alternative to Antibiotics Sales (2020-2031)
2.2.3 Global Alternative to Antibiotics Market Average Price (2020-2031)
2.3 Alternative to Antibiotics by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Antimicrobial Proteins
2.3.3 Bacteriophages
2.3.4 Probiotics
2.3.5 Other
2.4 Alternative to Antibiotics by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Drugs
2.4.3 Food & Beverage
2.4.4 Dietary Supplements
3 Market Competitive Landscape by Manufacturers
3.1 Global Alternative to Antibiotics Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Alternative to Antibiotics Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Alternative to Antibiotics Revenue of Manufacturers (2020-2025)
3.4 Global Alternative to Antibiotics Average Price by Manufacturers (2020-2025)
3.5 Global Alternative to Antibiotics Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Alternative to Antibiotics, Product Type & Application
3.8 Global Manufacturers of Alternative to Antibiotics, Established Date
3.9 Global Alternative to Antibiotics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 DSM
4.1.1 DSM Company Information
4.1.2 DSM Business Overview
4.1.3 DSM Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.1.4 DSM Alternative to Antibiotics Product Portfolio
4.1.5 DSM Recent Developments
4.2 BioGaia
4.2.1 BioGaia Company Information
4.2.2 BioGaia Business Overview
4.2.3 BioGaia Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.2.4 BioGaia Alternative to Antibiotics Product Portfolio
4.2.5 BioGaia Recent Developments
4.3 Bioriginal
4.3.1 Bioriginal Company Information
4.3.2 Bioriginal Business Overview
4.3.3 Bioriginal Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Bioriginal Alternative to Antibiotics Product Portfolio
4.3.5 Bioriginal Recent Developments
4.4 Biosearch Life
4.4.1 Biosearch Life Company Information
4.4.2 Biosearch Life Business Overview
4.4.3 Biosearch Life Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Biosearch Life Alternative to Antibiotics Product Portfolio
4.4.5 Biosearch Life Recent Developments
4.5 China-Biotics
4.5.1 China-Biotics Company Information
4.5.2 China-Biotics Business Overview
4.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.5.4 China-Biotics Alternative to Antibiotics Product Portfolio
4.5.5 China-Biotics Recent Developments
4.6 Chr. Hansen
4.6.1 Chr. Hansen Company Information
4.6.2 Chr. Hansen Business Overview
4.6.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Chr. Hansen Alternative to Antibiotics Product Portfolio
4.6.5 Chr. Hansen Recent Developments
4.7 Danone
4.7.1 Danone Company Information
4.7.2 Danone Business Overview
4.7.3 Danone Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Danone Alternative to Antibiotics Product Portfolio
4.7.5 Danone Recent Developments
4.8 DuPont(Danisco)
4.8.1 DuPont(Danisco) Company Information
4.8.2 DuPont(Danisco) Business Overview
4.8.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.8.4 DuPont(Danisco) Alternative to Antibiotics Product Portfolio
4.8.5 DuPont(Danisco) Recent Developments
4.9 Ganeden
4.9.1 Ganeden Company Information
4.9.2 Ganeden Business Overview
4.9.3 Ganeden Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Ganeden Alternative to Antibiotics Product Portfolio
4.9.5 Ganeden Recent Developments
4.10 Glory Biotech
4.10.1 Glory Biotech Company Information
4.10.2 Glory Biotech Business Overview
4.10.3 Glory Biotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Glory Biotech Alternative to Antibiotics Product Portfolio
4.10.5 Glory Biotech Recent Developments
4.11 Greentech
4.11.1 Greentech Company Information
4.11.2 Greentech Business Overview
4.11.3 Greentech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Greentech Alternative to Antibiotics Product Portfolio
4.11.5 Greentech Recent Developments
4.12 Lallemand
4.12.1 Lallemand Company Information
4.12.2 Lallemand Business Overview
4.12.3 Lallemand Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Lallemand Alternative to Antibiotics Product Portfolio
4.12.5 Lallemand Recent Developments
4.13 Morinaga Milk Industry
4.13.1 Morinaga Milk Industry Company Information
4.13.2 Morinaga Milk Industry Business Overview
4.13.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
4.13.5 Morinaga Milk Industry Recent Developments
4.14 Novozymes
4.14.1 Novozymes Company Information
4.14.2 Novozymes Business Overview
4.14.3 Novozymes Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Novozymes Alternative to Antibiotics Product Portfolio
4.14.5 Novozymes Recent Developments
4.15 Probi
4.15.1 Probi Company Information
4.15.2 Probi Business Overview
4.15.3 Probi Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Probi Alternative to Antibiotics Product Portfolio
4.15.5 Probi Recent Developments
4.16 Sabinsa
4.16.1 Sabinsa Company Information
4.16.2 Sabinsa Business Overview
4.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Sabinsa Alternative to Antibiotics Product Portfolio
4.16.5 Sabinsa Recent Developments
4.17 Synbiotech
4.17.1 Synbiotech Company Information
4.17.2 Synbiotech Business Overview
4.17.3 Synbiotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Synbiotech Alternative to Antibiotics Product Portfolio
4.17.5 Synbiotech Recent Developments
4.18 UAS Laboratories
4.18.1 UAS Laboratories Company Information
4.18.2 UAS Laboratories Business Overview
4.18.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.18.4 UAS Laboratories Alternative to Antibiotics Product Portfolio
4.18.5 UAS Laboratories Recent Developments
4.19 Valio
4.19.1 Valio Company Information
4.19.2 Valio Business Overview
4.19.3 Valio Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.19.4 Valio Alternative to Antibiotics Product Portfolio
4.19.5 Valio Recent Developments
4.20 Yakult
4.20.1 Yakult Company Information
4.20.2 Yakult Business Overview
4.20.3 Yakult Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.20.4 Yakult Alternative to Antibiotics Product Portfolio
4.20.5 Yakult Recent Developments
4.21 Nestle
4.21.1 Nestle Company Information
4.21.2 Nestle Business Overview
4.21.3 Nestle Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.21.4 Nestle Alternative to Antibiotics Product Portfolio
4.21.5 Nestle Recent Developments
5 Global Alternative to Antibiotics Market Scenario by Region
5.1 Global Alternative to Antibiotics Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Alternative to Antibiotics Sales by Region: 2020-2031
5.2.1 Global Alternative to Antibiotics Sales by Region: 2020-2025
5.2.2 Global Alternative to Antibiotics Sales by Region: 2026-2031
5.3 Global Alternative to Antibiotics Revenue by Region: 2020-2031
5.3.1 Global Alternative to Antibiotics Revenue by Region: 2020-2025
5.3.2 Global Alternative to Antibiotics Revenue by Region: 2026-2031
5.4 North America Alternative to Antibiotics Market Facts & Figures by Country
5.4.1 North America Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Alternative to Antibiotics Sales by Country (2020-2031)
5.4.3 North America Alternative to Antibiotics Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Alternative to Antibiotics Market Facts & Figures by Country
5.5.1 Europe Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Alternative to Antibiotics Sales by Country (2020-2031)
5.5.3 Europe Alternative to Antibiotics Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Alternative to Antibiotics Market Facts & Figures by Country
5.6.1 Asia Pacific Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Alternative to Antibiotics Sales by Country (2020-2031)
5.6.3 Asia Pacific Alternative to Antibiotics Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Alternative to Antibiotics Market Facts & Figures by Country
5.7.1 South America Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Alternative to Antibiotics Sales by Country (2020-2031)
5.7.3 South America Alternative to Antibiotics Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Alternative to Antibiotics Market Facts & Figures by Country
5.8.1 Middle East and Africa Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Alternative to Antibiotics Sales by Country (2020-2031)
5.8.3 Middle East and Africa Alternative to Antibiotics Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Alternative to Antibiotics Sales by Type (2020-2031)
6.1.1 Global Alternative to Antibiotics Sales by Type (2020-2031) & (K Units)
6.1.2 Global Alternative to Antibiotics Sales Market Share by Type (2020-2031)
6.2 Global Alternative to Antibiotics Revenue by Type (2020-2031)
6.2.1 Global Alternative to Antibiotics Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Alternative to Antibiotics Revenue Market Share by Type (2020-2031)
6.3 Global Alternative to Antibiotics Price by Type (2020-2031)
7 Segment by Application
7.1 Global Alternative to Antibiotics Sales by Application (2020-2031)
7.1.1 Global Alternative to Antibiotics Sales by Application (2020-2031) & (K Units)
7.1.2 Global Alternative to Antibiotics Sales Market Share by Application (2020-2031)
7.2 Global Alternative to Antibiotics Revenue by Application (2020-2031)
7.2.1 Global Alternative to Antibiotics Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Alternative to Antibiotics Revenue Market Share by Application (2020-2031)
7.3 Global Alternative to Antibiotics Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Alternative to Antibiotics Value Chain Analysis
8.1.1 Alternative to Antibiotics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Alternative to Antibiotics Production Mode & Process
8.2 Alternative to Antibiotics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Alternative to Antibiotics Distributors
8.2.3 Alternative to Antibiotics Customers
9 Global Alternative to Antibiotics Analyzing Market Dynamics
9.1 Alternative to Antibiotics Industry Trends
9.2 Alternative to Antibiotics Industry Drivers
9.3 Alternative to Antibiotics Industry Opportunities and Challenges
9.4 Alternative to Antibiotics Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.